NCT06628622 - A Study to Test Whether BI 1356225 Improves Impulsive Behavior in Men With Opioid Use Disorder Who Are Taking Buprenorphine | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

January 27, 2025

Primary Completion Date

May 14, 2026

Study Completion Date

June 3, 2026

Conditions

Opioid Use Disorder

Interventions

DRUG

BI 1356225

DRUG

Placebo

Trial Locations (6)

RECRUITING

Virginia Commonwealth University, Richmond

RECRUITING

iResearch Atlanta, Decatur

NOT_YET_RECRUITING

ERG Clinical Research - Houston, Houston

RECRUITING

University of California Los Angeles, Los Angeles

RECRUITING

Collaborative Neuroscience Research, LLC, Los Alamitos, Los Alamitos

RECRUITING

Hassman Research Institute-Marlton-66897, Marlton